Several single-dose studies comparing acute bronchodilation induced by ipratropium bromide with salbutamol have shown that salbutamol was more effective than ipratropium in asthma treatment.
optimising bronchodilation and tailoring the treatment selection to the patient needs. This in turn could help to optimally manage symptoms in order to maintain and improve patient quality of life ...
TURIN, Italy I October 30, 2024 I Kither Biotech, a clinical-stage biotech company focused on innovative therapies for respiratory diseases, today announced ...
Its mechanism means that it provides both bronchodilation and anti-inflammatory properties in one molecule, and is administered using a jet nebuliser that is suitable for patients who may have ...
He said ensifentrine will "change the treatment paradigm" for COPD by providing bronchodilation and anti-inflammatory properties in one compound. In both studies, it was administered on top of ...
Trials 3–5 were 48-week, randomized, double-blind, placebo-controlled, trials that evaluated bronchodilation and effects on COPD exacerbations. Trials 1-4 included both the tiotropium Respimat 5 ...
In a randomized, placebo-controlled clinical study, the administration of Spiriva Handihaler in the morning or in the evening to 105 patients with COPD showed that bronchodilation was maintained ...
Overall, cilomilast is well tolerated, with 4 clinical trials encompassing 1151 patients reporting the most common adverse effects to be diarrhea, nausea, dizziness, and headaches. [10,11,12,13 ...